{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360294647479408384.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1186/s13046-020-01601-2"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1186/s13046-020-01601-2.pdf"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/article/10.1186/s13046-020-01601-2/fulltext.html"}}],"dc:title":[{"@value":"Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:p>In a large number of cancer types, treatment selection depends on the presence of specific tumor biomarkers. Due to the dynamic nature of cancer, very often these predictive biomarkers are not uniformly present in all cancer cells. Tumor heterogeneity represents indeed one of the main causes of therapeutic failure, and its decoding remains a major ongoing challenge in the field.</jats:p><jats:p>Liquid biopsy is the sampling and analysis of non-solid biological tissue often through rapid and non-invasive methods, which allows the assessment in real-time of the evolving landscape of cancer. Samples can be obtained from blood and most other bodily fluids. A blood-based liquid biopsy can capture circulating tumor cells and leukocytes, as well as circulating tumor-derived nucleic acids.</jats:p><jats:p>In this review, we discuss the current and possibly future applications of blood-based liquid biopsy in oncology, its advantages and its limitations in clinical practice. We specifically focused on its role as a tool to capture tumor heterogeneity in metastatic cancer patients.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380294647479408392","@type":"Researcher","foaf:name":[{"@value":"Marco Russano"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408395","@type":"Researcher","foaf:name":[{"@value":"Andrea Napolitano"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408396","@type":"Researcher","foaf:name":[{"@value":"Giulia Ribelli"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408385","@type":"Researcher","foaf:name":[{"@value":"Michele Iuliani"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408390","@type":"Researcher","foaf:name":[{"@value":"Sonia Simonetti"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408384","@type":"Researcher","foaf:name":[{"@value":"Fabrizio Citarella"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408388","@type":"Researcher","foaf:name":[{"@value":"Francesco Pantano"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408394","@type":"Researcher","foaf:name":[{"@value":"Emanuela Dell’Aquila"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408397","@type":"Researcher","foaf:name":[{"@value":"Cecilia Anesi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408389","@type":"Researcher","foaf:name":[{"@value":"Nicola Silvestris"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408398","@type":"Researcher","foaf:name":[{"@value":"Antonella Argentiero"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408386","@type":"Researcher","foaf:name":[{"@value":"Antonio Giovanni Solimando"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408393","@type":"Researcher","foaf:name":[{"@value":"Bruno Vincenzi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408391","@type":"Researcher","foaf:name":[{"@value":"Giuseppe Tonini"}]},{"@id":"https://cir.nii.ac.jp/crid/1380294647479408387","@type":"Researcher","foaf:name":[{"@value":"Daniele Santini"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"17569966"}],"prism:publicationName":[{"@value":"Journal of Experimental & Clinical Cancer Research"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2020-05-27","prism:volume":"39","prism:number":"1","prism:startingPage":"95"},"reviewed":"false","dc:rights":["https://creativecommons.org/licenses/by/4.0","https://creativecommons.org/licenses/by/4.0"],"url":[{"@id":"https://link.springer.com/content/pdf/10.1186/s13046-020-01601-2.pdf"},{"@id":"https://link.springer.com/article/10.1186/s13046-020-01601-2/fulltext.html"}],"createdAt":"2020-05-27","modifiedAt":"2021-05-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360016864693249920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Relationship between perioperative oncological evaluation and recurrence using circulating tumor <scp>DNA</scp> with <scp><i>KRAS</i></scp> mutation in patients with colorectal cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431109287424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757191351552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593750726656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction"}]},{"@id":"https://cir.nii.ac.jp/crid/1390025119844399872","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"リキッドバイオプシーの有用性と課題"},{"@language":"en","@value":"The Utility and Challenges of Liquid Biopsy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390307435436895616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"細胞膜タンパク質を検出するトランジスタ型バイオセンサの開発に関するレビュー"},{"@language":"en","@value":"A Review of Development of a Transistor-based Biosensor for Detecting Cell Membrane Proteins"},{"@language":"ja-Kana","@value":"サイボウマク タンパクシツ オ ケンシュツ スル トランジスタガタ バイオセンサ ノ カイハツ ニ カンスル レビュー"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1186/s13046-020-01601-2"},{"@type":"CROSSREF","@value":"10.1002/cam4.4677_references_DOI_C0t1UD96pgfT4UZRUjudOZ3NPvl"},{"@type":"CROSSREF","@value":"10.1093/clinchem/hvaf045_references_DOI_C0t1UD96pgfT4UZRUjudOZ3NPvl"},{"@type":"CROSSREF","@value":"10.3390/cancers14133275_references_DOI_C0t1UD96pgfT4UZRUjudOZ3NPvl"},{"@type":"CROSSREF","@value":"10.1541/ieejsmas.146.65_references_DOI_C0t1UD96pgfT4UZRUjudOZ3NPvl"},{"@type":"CROSSREF","@value":"10.3390/life11090885_references_DOI_C0t1UD96pgfT4UZRUjudOZ3NPvl"},{"@type":"CROSSREF","@value":"10.3191/thermalmed.41.57_references_DOI_C0t1UD96pgfT4UZRUjudOZ3NPvl"}]}